ClinicalTrials.Veeva

Menu

Flexible Composite Next Generation Tissue Separating Mesh in Laparoscopic Incisional/Ventral Hernia Repair

E

Ethicon

Status

Completed

Conditions

Incisional Hernia
Ventral Hernia

Treatments

Device: NG-TSM

Study type

Observational

Funder types

Industry

Identifiers

NCT01162564
200-10-002

Details and patient eligibility

About

This is a multi-center, observational study of incisional/ventral hernia repair with NG-TSM laparoscopically. The study is not randomized and has a single treatment design assessing NG-TSM intra-operatively, its ease of use and handling characteristics.

Full description

The objectives of the study are to evaluate the ease of use of NG-TSM intra-operatively in laparoscopic incisional/ventral hernia repair, and assessing early outcomes post-operatively following mesh implantation, including seroma formation, hematoma, wound complications, infections, early recurrences, adverse events, and subject comfort, as well as health economic data to include quality of life, subject satisfaction data, time of procedure, length of stay, re-hospitalization, and extended hospitalization.

Enrollment

48 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subject must be able to provide written informed consent
  • Male or female subjects that are ≥ 18 years of age
  • Female subjects must be using adequate contraception, or be surgically sterile, postmenopausal or practicing abstinence, and not planning to become pregnant
  • Planned laparoscopic procedure to repair an abdominal incisional/ventral hernia that requires the addition of reinforcing or bridging material to obtain the desired surgical result

Exclusion criteria

  • Subjects with a potential growth as NGTSM will not stretch significantly
  • Female subjects who are pregnant on the day of implantation
  • Surgical site (mesh implantation site) that is classified as contaminated (acute, non purulent, inflamed) or dirty/infected (containing retained devitalized tissue and those that involve existing clinical infection or perforated viscera)
  • Subjects who have received investigational articles less than 30 days prior to enrollment or who are currently receiving investigational products or devices
  • Employees of the investigator or study center with direct involvement in the proposed study or other studies under the direction of that investigator or study center

Trial design

48 participants in 1 patient group

NG-TSM
Description:
Patients receiving NG-TSM to repair an abdominal incisional/ventral hernia
Treatment:
Device: NG-TSM

Trial contacts and locations

6

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems